Brain Ischemia in Alzheimer's Disease May Partly Counteract the Disruption of the Blood-Brain Barrier

被引:1
作者
Bateman, Grant A. [1 ,2 ]
Bateman, Alexander R. [3 ]
机构
[1] John Hunter Hosp, Dept Med Imaging, Newcastle, NSW 2310, Australia
[2] Newcastle Univ, Coll Hlth Med & Wellbeing, Sch Med & Publ Hlth, Callaghan Campus, Newcastle, NSW 2308, Australia
[3] Newcastle Univ, Coll Engn Sci & Environm, Sch Engn, Callaghan Campus, Newcastle, NSW 2308, Australia
关键词
Alzheimer's disease; blood-brain barrier; cerebral blood flow; CSF formation rate; glymphatic; ischemia; normal pressure hydrocephalus; NORMAL-PRESSURE HYDROCEPHALUS; MILD COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CEREBRAL PERFUSION; VENOUS-PRESSURE; FLOW; PATHOGENESIS; METABOLISM; PHYSIOLOGY; HUMANS;
D O I
10.3390/brainsci15030269
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: In normal pressure hydrocephalus (NPH) there is blood-brain barrier (BBB) disruption, which should increase the CSF formation rate (CSFfr) and, therefore, also increase the intracranial pressure (ICP). However, the ICP is normal in NPH. A lumped parameter study was performed to look at the interrelation between the ICP, cerebral blood flow (CBF), and the degree of BBB disruption in NPH. The model suggested that the CSFfr could be reduced in this condition if the BBB disruption was moderated by a reduction in the capillary transmural pressure (TMP) secondary to arteriolar constriction and a reduced CBF. In early Alzheimer's disease (AD), there is BBB disruption, reduced ICP, and global ischemia. This raises the possibility that the same physiology may occur in AD as occurs in NPH. Methods: A lumped parameter model previously used to describe the hydrodynamics of NPH was modified to investigate the effects of changes in CSF pressure and blood flow in patients with mild cognitive impairment (MCI) and AD. Results: The model indicates that the average capillary TMP is normal in MCI, but decreases as AD progresses. Removing CSF in AD patients during a tap test initially increases the capillary TMP. The brain in AD responds to a tap test by increasing its level of ischemia, and this reduces the capillary TMP. Conclusions: A hypothesis is put forward that the BBB disruption in AD is partially mitigated by the brain making itself ischemic. Modelling gives support to this hypothesis. The model can suggest a cause for the development of ischemic neuronal loss and amyloid accumulation secondary to glymphatic flow disruption as AD progresses.
引用
收藏
页数:16
相关论文
共 50 条
[41]   Hypertension, blood-brain barrier disruption and changes in intracranial pressure [J].
Colombari, Eduardo ;
Biancardi, Vinicia Campana ;
Colombari, Debora Simoes Almeida ;
Katayama, Pedro Lourenco ;
de Medeiros, Fernanda de Campos ;
Aitken, Andrew Vieira ;
Xavier, Carlos Henrique ;
Pedrino, Gustavo Rodrigues ;
Bragin, Denis E. .
JOURNAL OF PHYSIOLOGY-LONDON, 2025, 603 (08) :2245-2261
[42]   Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia [J].
Chi, Oak Z. ;
Hunter, Christine ;
Liu, Xia ;
Weiss, Harvey R. .
PHARMACOLOGY, 2008, 82 (01) :38-42
[43]   Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics [J].
Pan, Yijun ;
Nicolazzo, Joseph A. .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 135 :62-74
[44]   Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease [J].
Zhao, Ming ;
Jiang, Xue-Fan ;
Zhang, Hui-Qin ;
Sun, Jia-Hui ;
Pei, Hui ;
Ma, Li-Na ;
Cao, Yu ;
Li, Hao .
AGEING RESEARCH REVIEWS, 2021, 72
[45]   The Impairment of Blood-Brain Barrier in Alzheimer's Disease: Challenges and Opportunities with Stem Cells [J].
Lopez-Ornelas, Adolfo ;
Jimenez, Adriana ;
Perez-Sanchez, Gilberto ;
Rodriguez-Perez, Citlali Ekaterina ;
Corzo-Cruz, Alejandro ;
Velasco, Ivan ;
Estudillo, Enrique .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
[46]   Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease [J].
Dan, Yuet Ruh ;
Chiam, Keng-Hwee .
FRONTIERS IN BIOINFORMATICS, 2024, 4
[47]   Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease [J].
Chang, Rudy ;
Knox, Jillian ;
Chang, Jae ;
Derbedrossian, Aram ;
Vasilevko, Vitaly ;
Cribbs, David ;
Boado, Ruben J. ;
Pardridge, William M. ;
Sumbria, Rachita K. .
MOLECULAR PHARMACEUTICS, 2017, 14 (07) :2340-2349
[48]   Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease [J].
Roney, C ;
Kulkarni, P ;
Arora, V ;
Antich, P ;
Bonte, F ;
Wu, AM ;
Mallikarjuana, NN ;
Manohar, S ;
Liang, HF ;
Kulkarni, AR ;
Sung, HW ;
Sairam, M ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2005, 108 (2-3) :193-214
[49]   Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies [J].
Kurz, Carolin ;
Walker, Lauren ;
Rauchmann, Boris-Stephan ;
Perneczky, Robert .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2022, 48 (03)
[50]   In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease [J].
Schreiner, Thomas Gabriel ;
Creanga-Murariu, Ioana ;
Tamba, Bogdan Ionel ;
Lucanu, Nicolae ;
Popescu, Bogdan Ovidiu .
BIOMOLECULES, 2022, 12 (08)